ND Expert Sean Kassen: Statement on first FDA-approved treatment for Niemann-Pick Type C disease
Today, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.
“It has been almost 30 years to the day since Michael, Marcia and Christa Parseghian were diagnosed with Niemann-Pick Type C disease, eventually taking their young lives. Since that time the Parseghian family and so many other families, researchers and volunteers have worked tirelessly to advance our understanding of NPC and bring treatments to those affected by this devastating disease. Today marks a momentous occasion with the FDA approval of Miplyffa and the start of a new era with the first official medication for the treatment of NPC disease. We will continue to fight for NPC families until this disease is eradicated,” Kassen said.
The APMRF is a non-profit organization dedicated to finding a treatment or cure for Niemann-Pick Type C disease. The organization is named in honor of Ara Parseghian, the much beloved and well-known Notre Dame football coach, and was founded by Mike and Cindy Parseghian, whose three children — Michael, Marcia and Christa — were diagnosed with NPC in 1994.
Latest ND NewsWire
- Notre Dame receives $2.5 million gift from Coca-Cola to expand entrepreneurship programs into FIFA World Cup 26 host citiesThe Coca-Cola Company in North America has awarded a $2.5 million gift to the University of Notre Dame’s Urban Poverty and Business Initiative (UPBI). The initiative brings together universities and nonprofit organizations committed to alleviating poverty and helping low-income and underprivileged individuals launch and grow sustainable businesses. The gift will enable UPBI, housed within the University’s Keough School of Global Affairs, to expand its network of partner organizations across the United States and into Canada, including cities that will host the FIFA World Cup 26.
- Notre Dame, Beacon Health System announce new, multiyear research collaborationThe University of Notre Dame and Beacon Health System have announced a new, multiyear research collaboration. Through this agreement, Notre Dame and Beacon will jointly develop collaborative, health-focused research projects that are of interest to both organizations, particularly in the areas of oncology and health data.
- Cardinal Robert McElroy, archbishop of Washington, DC, to speak at Notre Dame Forum event on ‘Healing Our National Dialogue and Political Life’Cardinal Robert McElroy, archbishop of the Archdiocese of Washington, D.C., will join University President Rev. Robert A. Dowd, C.S.C., for a conversation titled “Healing Our National Dialogue and Political Life” at 4 p.m. Friday (Oct. 17) in Room 215/216, McKenna Hall, as part of the 2025-26 Notre Dame Forum on the theme “Cultivating Hope.” This event is free and open to the public.
- ND experts offer insight on ‘Dilexi Te’On Thursday (Oct. 9), Pope Leo XIV issued his first major document, “Dilexi Te” (“I Have Loved You”), addressed to all Christians and divided into five chapters. Below, experts from the University of Notre Dame’s College of Arts and Letters, Keough School of Global Affairs, Institute for Social Concerns and the Institute for Educational Initiatives respond to the document.
- Notre Dame’s Kellogg Institute partners with Vanderbilt University to launch 2025-26 democracy surveyThe University of Notre Dame’s Kellogg Institute for International Studies and Vanderbilt University’s Center for Global Democracy are partnering to advance one of the world’s leading surveys on attitudes toward democracy. Starting in October, the Center for Global Democracy, with support from the Kellogg Institute, will conduct the 2025-26 round of the AmericasBarometer, which tracks public opinion on democracy in 20 countries across the Americas.
- Notre Dame to award 2026 Evangelium Vitae Medal to Wm. David Solomon, founding director of the de Nicola Center for Ethics and CultureThe de Nicola Center for Ethics and Culture at the University of Notre Dame announced that the late Wm. David Solomon, associate professor of philosophy emeritus and founding director of the center, has been named the recipient of the 15th annual Notre Dame Evangelium Vitae Medal, the nation’s most important award for heroes of the pro-life movement. The medal will be presented to Solomon’s family at a special Mass and dinner May 1, 2026, at Notre Dame.